Hydroxy ritonavir

• UNSPSC Description:

  Hydroxy ritonavir is a metabolite of Ritonavir. Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS[1].

• Target Antigen:

  Drug Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/hydroxy-ritonavir.html

• Purity:

  97.0

• Solubility:

  10 mM in DMSO

• Smiles:

  O[C@H]([C@@H](NC(OCC1=CN=CS1)=O)CC2=CC=CC=C2)C[C@@H](NC([C@H](C(C)C)NC(N(C)CC3=CSC(C(C)(O)C)=N3)=O)=O)CC4=CC=CC=C4

• Molecular Weight:

  736.94

• References & Citations:

  [1]Mantripragad MKVVN, et, al. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method. J Chromatogr Sci. 2018 Mar 1;56(3):270-284.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  176655-56-4